BIO vs TNDM
Bio-Rad Laboratories Inc · Tandem Diabetes Care Inc
Relative return (rebased to 100)
Key stats
| Metric | BIO | TNDM |
|---|---|---|
| Price | $327.25 | $18.59 |
| Market Cap | $9.05B | $1.27B |
| P/E | 11.92 | — |
| P/B | 1.32 | 9.62 |
| P/S | 3.51 | 1.26 |
| ROE | 11.1% | -154.6% |
| Net Margin | 29.4% | -20.2% |
| Gross Margin | 51.9% | 53.8% |
| Revenue Growth | 0.7% | 7.9% |
| Dividend Yield | — | — |
| EPS | $27.46 | -$2.99 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.